首页> 外文期刊>Clinical and vaccine immunology: CVI >Genetic and Antigenic Diversity of the Surface Protective Antigen Proteins of Erysipelothrix rhusiopathiae
【24h】

Genetic and Antigenic Diversity of the Surface Protective Antigen Proteins of Erysipelothrix rhusiopathiae

机译:丹毒丹毒的表面保护性抗原蛋白的遗传和抗原多样性

获取原文
           

摘要

The surface protective antigen (Spa) protein of Erysipelothrix rhusiopathiae has been shown to be highly immunogenic and is a potential candidate for a new vaccine against erysipelas. In this study, we cloned and sequenced spa genes from all E. rhusiopathiae serovar reference strains as well as from a serovar 18 strain which was not classified as any species in the genus Erysipelothrix. Sequence analysis revealed that the Spa proteins could be classified into three molecular species, including SpaA, which was previously found in serovars 1a and 2, and the newly designated SpaB and SpaC proteins. The SpaA protein is produced by E. rhusiopathiae serovars 1a, 1b, 2, 5, 8, 9, 12, 15, 16, 17, and N, the SpaB protein is produced by E. rhusiopathiae serovars 4, 6, 11, 19, and 21, and the SpaC protein is produced only by serovar 18. The amino acid sequence similarity was high among members of each Spa type (96 to 99%) but low between different Spa types (~60%). The greatest diversity in Spa proteins was found in the N-terminal half of the molecule (50 to 57% similarity), which was shown to be involved in immunoprotection. Coinciding with this, immunoblot analysis revealed that rabbit antisera specific to each Spa reacted strongly with the homologous Spa protein but weakly with heterologous Spa proteins. A mouse cross-protection study showed that the three recombinant Spa (rSpa) proteins elicited complete protection against challenge with homologous strains but that the level of protection against challenge with heterologous strains varied depending on the rSpa protein used for immunization. Our study is the first to demonstrate sequence and antigenic diversity in Spa proteins and to indicate that rSpaC may be the most promising antigen for use as a vaccine component because of its broad cross-protectiveness.
机译:已证明 Erysipelothrix rhusiopathiae 的表面保护性抗原(Spa)蛋白具有高度的免疫原性,并且可能成为抗丹毒的新型疫苗的潜在候选者。在这项研究中,我们从所有 E基因克隆并测序了 spa 基因。类风湿病参考株以及来自Erysipelothrix属的未分类为任何种类的血清型18株。序列分析显示Spa蛋白可分为三个分子种类,包括先前在血清型1a和2中发现的SpaA,以及新指定的SpaB和SpaC蛋白。 SpaA蛋白由 E生产。狂犬病血清型1a,1b,2、5、8、9、12、15、16、17和N,由 E产生。类风湿病的血清型分别为4、6、11、19和21,而SpaC蛋白仅由血清型18产生。各Spa类型成员的氨基酸序列相似性较高(96%至99%),而不同的水疗类型(〜60%)。 Spa蛋白质的最大多样性出现在分子的N端一半(50%至57%的相似性),这表明它参与了免疫保护。与此同时,免疫印迹分析显示,每个Spa特异的兔抗血清与同源Spa蛋白反应强烈,而与异源Spa蛋白反应较弱。一项小鼠交叉保护研究表明,三种重组Spa(rSpa)蛋白引发了针对同源菌株攻击的完全保护,但是针对异源菌株攻击的保护水平则取决于用于免疫的rSpa蛋白。我们的研究首次证明Spa蛋白质中的序列和抗原多样性,并指出rSpaC可能是最有前途的抗原,因为它具有广泛的交叉保护作用,因此可以用作疫苗组分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号